ELLIOTT, ROBERT BARTLETT,SKINNER, STEPHEN JOHN MARTIN,TAN, PAUL LIP JIN
申请号：
CA2611483
公开号：
CA2611483C
申请日:
2006.06.07
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention is directed to the prevention or treatment of autoimmunediseases, and in particular, of type I diabetes, by administering atherapeutically effective amount of an implantable composition comprisingliving choroid plexus cells.
